3D-aldehyde COFs linkers represent a promising frontier in the realm of drug delivery. These innovative structures offer a three-dimensional framework with aldehyde functional groups strategically positioned, imparting unique chemical properties. The specific design of these COFs allows for precise control over pore size, surface area, and functionality. In the context of drug delivery, the 3D-aldehyde COFs serve as an ingenious platform for encapsulating and releasing therapeutic agents. The aldehyde groups can engage in versatile chemical interactions, enabling tailored drug loading and release kinetics. This targeted approach enhances drug stability and bioavailability while minimizing side effects.
Catalog: CDM-CH1283
MW: 393.3942
CAS No.: 443922-06-3
Catalog: CDM-CH1239
MW: 330.40134
CAS No.: 2243590-42-1
Catalog: CDM-CH1235
MW: 252.22008
CAS No.: 680575-17-1
Catalog: CDM-CH1279
MW: 432.50976
CAS No.: 2195343-70-3
Catalog: CDM-CH1277
MW: 621.68208
CAS No.: 1221509-80-3
Catalog: CDM-CH1290
MW: 391.41808
CAS No.: 2230887-26-8
Catalog: CDM-CH1280
MW: 462.49422
CAS No.: 2289758-98-9
Catalog: CDM-CH1287
MW: 393.3942
CAS No.: 1482413-54-6
Catalog: CDM-CH1291
MW: 678.81138
CAS No.: 705930-83-2
Catalog: CDM-CH1284
MW: 618.7179
CAS No.: 805246-78-0